Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line

Breast Cancer Research and Treatment

Volumn 56, Issue 3, 1999, Pages 203-217

  Cavanaugh, Philip G ^a   Jia, LiBin ^b   Zou, YiYu ^a   Nicolson, Garth L ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c INSTITUTE FOR MOLECULAR MEDICINE   (United States)

Author keywords

Breast neoplasms; Metastasis; Transferrin; Transferrin receptor

Indexed keywords

COMPLEMENTARY DNA; CYTOKERATIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST METASTASIS; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; LUNG METASTASIS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032699858     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006209714287     Document Type: Article

References (55)

1. Cavanaugh PG, Nicolson GL: Organ derived growth factors for organ metastasizing tumor cells. Cancer Bull 43: 9-16, 1991
2. Nicolson GL: Tumor and host molecules important in organ preference of metastasis. Semin Cancer Biol 2: 143-154, 1991
3. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. BBA 948: 175-224, 1988
4. Hujanen ES, Terranova VP: Migration of tumor cells to organ derived chemoattractants. Cancer Res 45: 3517-3521, 1985
5. Benke R, Schirrmacher V: Change in organotropism of mouse lymphoma variants associated with selective chemotactic responsiveness to organ-derived chomoattractants. Clin Exp Metastasis 9: 205-219, 1991
6. Glinsky GV: Cell adhesion and metastasis: is site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Crit Rev in Oncol/Hematol 14: 229-278, 1993
7. Nicolson GL, Dulski KM: Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 38, 280 294, 1986
8. Nicolson GL: Differential growth properties of metastatic large cell lymphoma cells in target organ-conditioned media. Exp Cell Res 168, 572-577, 1997
9. Cavanaugh PG, Nicolson GL: Purification and some properties of a lung derived growth factor that differentially stimulates the growth of tumor cells metastatic to the lung. Cancer Res 49: 3928-3933, 1989
10. r ≈ 66,000 lung derived (paracrine) growth factor that preferentially stimulates the in vitro proliferation of lung-metastasizing tumor cells. J Cell Biochem 43: 127-138, 1990
11. Cavanaugh PG, Nicolson GL: Lung derived growth factor that stimulates the growth of lung-metastasizing tumor cells: identification as transferrin. J Cell Biochem 47: 261-271, 1991
12. Rossi MC, Zetter BR: Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci 89: 6197-6201, 1992.
13. Stackpole dW, Kalbag SS, Groszek L: Acquisition of in vitro growth autonomy during B 16 melanoma malignant progression is associated with autocrine stimulation by transferrin and fibronectin. In Vitro Cell Dev Biol 31: 244-251, 1996
14. Rusciano D, Lorenzoni P, Burger MM: Murine models of liver metastasis. Invasion Metastasis 14: 349-361, 1994
15. Qian ZM, Tang PL: Mechanisms of iron uptake mammalian cells. Biochim Biophys Acta 1269: 205-214, 1995
16. De Silva DM, Askwith CC, Kaplan J: Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 76: 31-47, 1996
17. Greenberg GR, Hilfinger JM: Regulation of synthesis of ribonucleotide reductase and relationship to DNA replication in various systems. Prog Nucleic Acid Res Mol Biol 53: 345-395, 1996
18. Inoue T, Cavanaugh PG, Steck PA, Nicolson GL: Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol 156: 212-217, 1993
19. Van Muijen GN, Ruiter DJ, Hoefakker S, Johnson JP: Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker for metastasis. J Invest Dermatol 95: 65-69, 1990
20. Van Muijen GNP, Jansen KFJ, Cornelissen IMHA, Smeets DFCM, Beck JLM, Ruiter DJ: Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 48: 85-91, 1991
21. Shindelman JE, Ortmeyer AD, Sussman HH: Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells. Int J Cancer 27: 329-334, 1981
22. Wrba F, Ritzinger E, Reiner A, Holzner JH: Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study. Virchows Arch [A] 41: 69-73, 1986
23. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA: Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 15: 341-344, 1987
24. Yoda J, Yamnaka N, Saito T, Samukawa T, Tamura S, Kawaguchi T: Characterization of cell lines from metastatic maxillary cancer. J Oto-Rhino-Laryngol Soc Japan 97: 419-429, 1994
25. Whitney JF, dlark JM, Griffin TW, Gautam S, Leslie KO: Transferrin expression in nonsmall cell lung cancer: histopathologic and clinical correlates. Cancer 76: 20-25, 1995
26. Cavanaugh PG, Nicolson GL: Selection of metastatic rat mammary adenocarcinoma cells from a low metastatic population by growth response to transferrin (Abstract). Proc Amer Assoc Cancer Res 35: 46, 1994
27. Cavanaugh PG, Nicolson GL: The selection of a metastatic rat mammary adenocarcinoma subline from low metastatic parental cells by an in vitro process based on transferrin-mediated cellular proliferation. J Cell Physiol 174: 48-57, 1998
28. Neri A, Welch D, Kawaguchi T, Nicolson GL: Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst, 68: 507-517, 1982
29. Welch DR, Neri A, Nicolson GL: Comparison of "spontaneous" and "experimental" metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Inv Metastasis, 3: 65-80, 1983
30. Van Driel IR, Goding JW, Koch N: Plasma cell antigen PC-1 and the transferrin receptor in mouse, rat and hamster: serologic and biochemical analysis. J Immunol 134: 3987-3993, 1985
31. Turkewitz AP, Amatruda JF, Borhani D, Harrison SC, Schwartz AL: A high yield purification of the human transferrin receptor and properties of its major extracellular fragment. J Biol Chem 263: 8318-8325, 1988
32. Keung W, Silher E, Eppenberger U: Quantification of cells cultured on 96 well plates. Anal Biochem 182: 16-19, 1989
33. Zhang RD, Fidler IJ, Price JE: Relative malignant potential of human breast carcinoma lines established form pleural effusions and a brain metastasis. Inv Metastasis 11: 204-215, 1991
34. Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis ofhuman breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721, 1990
35. Domingo DL, Trowbridge IS: Characterization of the human transferrin receptor produced in a baculovirus expression system. J Biol Chem 263: 13386-13392, 1988
36. Yu D, Wang S-S, Dulski KM, Tsai CM, Nicolson GL, Hung MC: c-erb/neu Overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 54: 3260-3266, 1994
37. Yu D, Hung MC: Expression of activated rat neu oncogene is sufficient to induced experimental metastasis in 3T3 cells. Oncogene 6: 1991-1996, 1991
38. Vousden KH, Eccles SA, Purvies H, Marshall CJ: Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene. Int J Cancer 37: 425-433, 1989
39. Bromberg ME, Konigsberg WH, Madison JF. Pawashe A, Garen A: Tissue factor promotes melanoma metastasis by a pathway independent of coaagulation. Proc Natl Acad Sci USA 92: 8205-8209, 1995
40. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickman, RB, Kern FG: Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovarectomised or tamoxifen-treated athymic nude mice. Cancer Res 53: 2168-2177, 1993
41. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T: Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD 13. Clin Exp Metastasis 13: 337-344, 1995
42. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M: Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 57: 2295-2303, 1997
43. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K, Takada Y: Induction of experimental bone metastasis in mice by transfection of integrin a4b1 into tumor cells. Am J Pathol 148: 55-61, 1996
44. Meek J, Adamson ED: Transferrin in foetal and adult mouse tissues: synthesis, storage and secretion. J Embryol exp Morph 86: 205-218, 1985
45. Salmeron A, Borroto A, Fresno M, Crumpton MJ, Ley SC, Alarcon B: Transferrin receptor induces tyrosine phosphorylation in T cells and is physically associated with the TCR ζ-chain. J Immunol 154: 1675-1683, 1995
46. Alacantra O, Javors M, Boldt DH: Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron. Blood 77: 1290-1297, 1991
47. Carlevaro MF, Albini A, Ribatti D, Gentili C, Benelli R, Cermelli S, Cancedda R, Cancedda FD: Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol 136: 1375-1384, 1997
48. Sanders EJ: Changes in the transferrin requirement of cultured chick mesoderm cells during early differentiation. J Embryol Exp Morph 95: 81-93, 1986
49. Bhatti RA, Gadarowski JJ, Ray PS: Metastatic behavior of prostatic tumor as influenced by the hematopoetic and hematogenous factors. Tumor Biol 18: 1-5, 1997
50. Sasaki K, Zak O, Aisen P: Antisense suppression of transferrin gene expression in a human hepatoma cell (HuH-7) line. Amer J Hematol 42: 74-80, 1993
51. Nascimento ALTO, Meneghini R: Cells transfected with transferrin receptor cDNA lacking the iron regulatory domain become more sensitive to the DNA-damaging action of oxidative stress. Carcinogenesis 16: 1335-1338, 1995
52. Owen D, Kuhn LC: Noncoding 3′ sequences of the transferrin receptor gene are required for mRNA regulation by iron. EMBO J 6: 1287-1293, 1987
53. Lichtner RB, Kaufmann AM, Kittmann A, Rohde-Schulz B, Walter J, Williams L, Ullrich A, Schirrmacher V, Khazaic K: Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells. Oncogene 10: 1823-1832, 1995
54. Elliot RL, Stjernholm R, Elliot MC: Preliminary evaluation of platinum transferrin (MTPC-63) as a potential nontoxic treatment for breast cancer. Cancer Detect Prev 12: 469-480, 1988
55. Kemp JD, Cardillo T, Stewart BC, Kehrber SE, Weiner G, Hedlund B, Naumann PW: Inhibition of lymphoma growth in vivo by combined treatment with hydroxylethyl starch defcroxamine conjugate and IgG monoclonal antibodies against the transferrin receptor. Cancer Res 55: 3817-3824, 1995